Puberty: Gonadarche and adrenarche

Yen & Jaffe's Reproductive Endocrinology: Expert Consult - Online and Print

Volumn , Issue , 2009, Pages 395-431

  Witchel, Selma Feldman ^a,b   Plant, Tony M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053638224     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4907-4.00017-6     Document Type: Chapter

References (501)

1. Webster's Third New International Dictionary of the English Language (unabridged) 1961, G & C Merriam, Springfield, MA. P.B. Gove (Ed.).
2. Reiter E.O., Fuldauer V.G., Root A.W. Secretion of the adrenal androgen dehydroepiandrosterone sulfate during normal infancy, childhood, and adolescence, in sick children and in children with endocrinologic abnormalities. J Pediatr 1977, 90:766.
3. Conley A.J., Pattison J.C., Bird I.M. Variations in adrenal androgen production among (nonhuman) primates. Semin Reprod Med 2004, 22:311.
4. Grumbach M.M., Styne D.M. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. Williams Textbook of Endocrinology 1992, 139. WB Saunders, Philadelphia. ed 8. J.D. Wilson, D.W. Foster (Eds.).
5. Plant T.M., Witchel S. Knobil and Neill's Physiology of Reproduction 2006, vol 2:2177. Elsevier, San Diego. ed 3. J.R.G. Challis, D.M. de Kretser, J.D. Neill (Eds.).
6. Herman-Giddens M.E., Slora E.J., Wasserman R.C., et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings Network. Pediatrics 1997, 99:505.
7. Midyet L.K., Moore W.V., Jacobson J.D. Are pubertal changes in girls before age eight benign?. Pediatrics 2003, 111:47.
8. O'Dea L.S., Lee P.A. Delayed puberty. Pediatric and Adolescent Gynecology 2001, 72. WB Saunders, Philadelphia. ed 2. J.S. Sanfilippo, D. Muram, J. Dewhurst, P.A. Lee (Eds.).
9. Giorlandino C., Gleicher N., Taramanni C., et al. Ovarian development of the female child and adolescent. I. Morphology. Int J Gynaecol Obstet 1989, 29:57.
10. Biro E.M., Lucky A.W., Huster G.A., et al. Hormonal studies and physical maturation in adolescent gynecomastia. J Pediatr 1990, 116:450.
11. luliano-Burns S., Mirwadl R.L., Bailey D.A. Timing and magnitude of peak height velocity and peak tissue velocities for early, average, and late maturing boys and girls. Am J Hum Biol 2001, 13:1.
12. Vizmanos B., Marti-Henneberg C., Cliville R., et al. Age of pubertal onset affects the intensity and duration of pubertal growth peak but not final height. Am J Hum Biol 2001, 13:409.
13. Hauspie R.C., Vercauteren M., Susanne C. Secular changes in growth. Horm Res 1996, 45:8.
14. Huen K.F., Leung S.S.F., Lau J.T.F., et al. Secular trend in the sexual maturation of Southern Chinese girls. Acta Paediatr 1997, 86:1121.
15. Fredriks A.M., van Buuren S., Burgmeijer R.J.F., et al. Continuing positive secular growth change in the Netherlands 1955-1997. Ped Res 2000, 47:316.
16. Adams Hillard PJ Menstruation in young girls: a clinical perspective. Obstet Gynecol 2002, 99:655.
17. Buck Louis G.M., Gray L.E., Marcus M., et al. Environmental factors and puberty timing: expert panel research needs. Pediatrics 2008, 121(Suppl 3):S192.
18. Herman-Giddens M.E., Wang L., Koch G. Secondary sexual characteristics in boys. Arch Pediatr Adolesc Med 2001, 155:1022.
19. Wu T., Mendola P., Buck G.M. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics 2002, 110:752.
20. Chumlea W.C., Schubert C.M., Roche A.F., et al. Age at menarche and racial comparisons in US girls. Pediatrics 2003, 111:110.
21. Karpati A.M., Rubin C.H., Kieszak S.M., et al. Statures and pubertal stage assessment in American boys: the 1988-1994 Third National Health and Nutrition Examination Survey. J Adolesc Health 2002, 30:205.
22. Rainey W.E., Carr B.R., Sasano H., et al. Dissecting human adrenal androgen production. Trends Endocrinol Metab 2002, 13:234.
23. Auchus R.J., Lee T.C., Miller W.L. Cytochrome b 5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 1998, 273:3158.
24. Ghayee H.K., Auchus R.J. Basic concepts and recent developments in human steroid hormone biosynthesis. Rev Endocr Metab Disord 2007, 8:289.
25. Adamski J., Jakob F.J. A guide to 17 ?-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2001, 171:1.
26. Labrie F., Luu-The Y Lin S.X., et al. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000, 25:1.
27. Geissler W.M., Davis D.L., Wu L., et al. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydro-genase 3. Nat Genet 1994, 7:34.
28. Rosner W. Plasma steroid-binding proteins. Endocrinol Metab Clin North Am 1991, 20:697.
29. Carson-Jurica M.A., Schrader W.T. O'Malley BW. Steroid receptor family: structure and functions. Endocr Rev 1990, 11:201.
30. Losel R.M., Falkenstein E., Feuring M., et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 2003, 83:965.
31. Belanger A., Hum D.W., Beaulieu M., et al. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 1998, 65:301.
32. Boime I., Garcia-Campayo V., Hsueh A.J.W. The glucoprotein hormones and their receptors. Yen and Jaffe's Reproductive Endocrinology 2004, WB Saunders, Philadelphia. ed 5. J.F. Strauss, R. Barbieri (Eds.).
33. Zeleznik A.J., Pohl C.R. Control of follicular development, corpus luteum function, the maternal recognition of pregnancy, and the neuroendocrine regulation of the menstrual cycle in higher primates. Knobil and Neill's Physiology of Reproduction, ed 3 2006, vol 2:2449. Elsevier, San Diego. J.R.G. Challis, D.M. de Kretser, J.D. Neill (Eds.).
34. Plant T.M., Marshall G.R. The functional significance of follicle-stimulating hormone in spermatogenesis and the control of its secretion in male primates. Endocr Rev 2001, 22:764.
35. Vale W., Rivier C., Hsueh A., et al. Chemical and biological characterization of the inhibin family of protein hormones. Rec Progr Horm Res 1988, 44:1.
36. Illingworth P.J., Groome N.P., Byrd W., et al. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996, 81:1321.
37. Crofton P.M., Evans A.E.M., Groome N.P., et al. Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH, and testosterone. Clin Endocrinol 2002, 56:215.
38. Andersson A.M., Skakkebaek N.E. Serum inhibin B levels during male childhood and puberty. Mol Cell Endocrinol 2001, 180:103.
39. Crofton P.M., Evans A.E.M., Groome N.P., et al. Dimeric inhibins in girls from birth to adulthood: relationship with age, pubertal stage, FSH and oestradiol. Clin Endocrinol 2002, 56:223.
40. Sehested A., Juul A., Andersson A.M., et al. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab 2000, 85:1634.
41. Lahlou N., Chabbert-Buffet N., Christin-Maitre S., et al. Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B?. Hum Reprod 1999, 14:1190.
42. Chabbert Buffet N., Djakoure C., Maitre S.C., et al. Regulation of the human menstrual cycle. Front Neuroendocrinol 1998, 19:151.
43. Lee M.M., Donahoe P.K., Hasegawa T., et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996, 81:571.
44. Herbison A.E. Knobil and Neill's Physiology of Reproduction 2006, vol 1:1415. Raven Press, New York. ed 3. J.D. Neill (Ed.).
45. Jeong K.-H., Kaisesr U.B. Knobil and Neill's Physiology of Reproduction 2006, vol 1.:1635. Elsevier, San Diego. ed 3. J.R.G. Challis, D.M. de Kretser, J.D. Neill (Eds.).
46. White R.B., Wisen J.A., Katsen T.L., et al. Second gene for gonadotropin-releasing hormone in humans. Proc Natl Acad Sci 1998, 95:305.
47. Neill J.D., Duck L.W., Sellers J.C., et al. A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates. Biochem Biophys Res Commun 2001, 282:1012.
48. Kriegsfeld L.J., Mei D.F., Bentley G.E., et al. Identifiction and characterization of a gonadotropin-inhibitory system in the brains of mammals. Proc Natl Acad Sci U S A 2006, 103:2410.
49. Plant T.M. Gonadal regulation of hypothalamic gonadotropin-releasing hormone release in primates. Endocr Rev 1986, 7:75.
50. Boepple P.A., Hayes F.J., Dwyer A.A., et al. Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function. J Clin Endocrinol Metab 2008, 93:1809.
51. Raven G., de Jong F.H., Kaufman J.M., et al. In men, peripheral estradiol levels directly reflect the ation of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. J Clin Endocrinol Metab 2006, 91:3324.
52. Pitteloud N., Dwyer A.A., DeCruz S., et al. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab 2008, 93:784.
53. Schwarting G.A., Wierman M.E., Tobet S.A. Gonadotropin-releasing hormone neuronal migration. Semin Reprod Med 2007, 25:305.
54. Wray S. Molecular mechanisms for migration of placodally derived GnRH neurons. Chem Senes 2002, 27:569.
55. Dellovade T.L., Hardelin J.P., Soussi-Yanicostas N., et al. Anosmin-1: immunoreactivity during embryogenesis in a primitive eutherian mammal. Dev Brain Res 2003, 140:157.
56. Pitteloud N., Zhang C., Pignatelli D., et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A 2007, 104:17447.
57. Wildt L., Marshall G., Knobil E. Experimental induction of puberty in the infantile female rhesus monkey. Science 1980, 207:1373.
58. Watanabe G., Terasawa E. In vivo release of luteinizing hormone releasing hormone increases with puberty in the female rhesus monkey. Endocrinology 1989, 125:92.
59. Plant T.M. Neurobiological bases underlying the control of the onset of puberty in the rhesus monkey: a representative higher primate. Frontiers Neuroendocrinol 2001, 22:107.
60. Plant T.M., Gay V.L., Marshall G.R., et al. Puberty in monkeys is triggered by chemical stimulation of the hypothalamus. Proc Natl Acad Sci U S A 1989, 86:2506.
61. Karsch F.J., Cummins J.T., Thomas G.B., et al. Steroid feedback inhibition of pulsatile secretion of gonadotropin-releasing hormone in the ewe. Biol Reprod 1987, 36:1207.
62. Wu F.C.W., Butler G.E., Kelnar C.J.H., et al. Ontogeny of pulsatile gonadotropin releasing hormone secretion from midchildhood, through puberty, to adulthood in the human male: a study using deconvolution analysis and an ultrasensitive immunofluorometric assay. J Clin Endocrinol Metab 1996, 81:1798.
63. Bridges N.A., Matthews D.R., Hindmarsh P.C., et al. Changes in gonadotrophin secretion during childhood and puberty. J Endocrinol 1994, 141:169.
64. Wennink J.M.B., Delemarre-van de Waal H.A., Schoemaker R., et al. Luteinizing hormone and follicle stimulating hormone secretion patterns in boys throughout puberty measured using highly sensitive immunoradiometric assays. Clin Endocrinol 1989, 31:551.
65. Mitamura R., Yano K., Suzuki N., et al. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, and testosterone secretion before the onset of male puberty. J Clin Endocrinol Metab 1999, 84:29.
66. Mitamura R., Yano K., Suzuki N., et al. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol secretion before the onset of female puberty in short children. J Clin Endocrinol Metab 2000, 85:1074.
67. Wennink J.M.B., Dellemarre-van de Waal H.A., Schoemaker R., et al. Luteinizing hormone and follicle stimulating hormone secretion patterns in girls throughout puberty measured using highly sensitive immunoradiometric assays. Clin Endocrinol 1990, 33:333.
68. Suter K.J., Pohl C.R., Plant T.M. The pattern and tempo of the pubertal reaugmentation of open-loop pulsatile gonadotropin-releasing hormone release assessed indirectly in the male rhesus monkey. (Macaca mulatta). Endocrinology 1998, 139:2774.
69. Conte F.A., Grumbach M.M., Kaplan S.L. A diphasic pattern of gonadotropin secretion in patients with the syndrome of gonadal dysgenesis. J Clin Endocrinol Metab 1975, 40:670.
70. Terasawa E., Fernandez D.L. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev 2001, 22:111.
71. Popa S.M., Clifton D.K., Steiner R.A. The role of kisspeptins and GPR54 in the neuroendocrine regulation of reproduction. Annu Rev Physiol 2008, 70:213.
72. Plant T.M. The role of KiSS-1 in the regulation of puberty in higher primates. Euro J Endocrinol 2006, 155:S11.
73. Roa J., Aguilar E., Dieguez C., et al. New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Front Neuroendocrinol 2008, 29:48.
74. Seminara S.B. Kisspeptin in reproduction. Semin Reprod Med 2007, 25:337.
75. Dhillo W.S., Chaudhri O.B., Patterson M., et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 2005, 90:6609.
76. Han S.K., Gottsch M.L., Lee K.J., et al. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci 2005, 25:11349.
77. de Roux N., Genin E., Carel J.C., et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003, 100:10972.
78. Seminara S.B., Messager S., Chatzidaki E.E., et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003, 349:1614.
79. Semple R.K., Achermann J.C., Ellery J., et al. Two novel missense mutations in GPR54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005, 90:1849.
80. Teles M.G., Bianco S.D., Brito V.N., et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008, 358:709.
81. Shahab M., Mastronardi C., Seminara S.B., et al. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci U S A 2005, 102:2129.
82. Keen KL, Wegner FH, Bloom SR, et al. An increase in kisspeptin-54 release occurs with the pubertal increase in LHRH-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology 146(1):156.
83. Plant T.M., Ramaswamy S., DiPietro M.J. Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges. Endocrinology 2006, 147:1007.
84. Rometo A.M., Krajewski S.J., Voytko M.L., et al. Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. J Clin Endocrinol Metab 2007, 92:2744.
85. Ramaswamy S., Guerriero K.A., Gibbs R.B., et al. Structural interactions between kisspeptin and GnRH neurons in the mediobasal hypothalamus of the male rhesus monkey (Macaca mulatta) as revealed by double immunofluorescence and confocal microscopy. Endocrinology 2008, 149(9):4387.
86. de Tassigny X.D., Fagg L.A., Carlton M.B., et al. Kisspeptin can stimulate GnRH release by a direct action at GnRH nerve terminals. Endocrinology 2008, 149(8):3926.
87. Zhang C., Roepke T.A., Kelly M.J., et al. Kisspeptin depolarizes gonadotropin-releasing hormone neurons through activation of TRPC-like cationic channels. J Neurosci 2008, 28:4423.
88. Liu X, Lee K, Herbison AE. Kisspeptin excites gonadotropin-releasing hormone (GnRH) neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels. Endocrinology 149(9):4605.
89. Seminara S.B., DiPietro M.J., Ramaswamy S., et al. Continuous human metastin 45-54 infusion desensitizes GPR54-induced GnRH release monitored indirectly in the juvenile male rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology 2006, 147:2122.
90. Hansson E., Ronnback L. Glial neuronal signaling in the central nervous system. FASEB J 2003, 17:341.
91. Ojeda S.R., Ma Y.J., Lee B.J., et al. Glia-to-neuron signaling and the neuroendocrine control of female puberty. Rec Prog Horm Res 2000, 55:197.
92. El Majdoubi M., Sahu A., Ramaswamy S., et al. Neuropeptide Y: a hypothalamic brake restraining the onset of puberty in primates. Proc Natl Acad Sci U S A 2000, 97:6179.
93. Plant T.M., Shahab M. Neuroendocrine mechanisms that delay and initiate puberty in higher primates. Physiol Behav 2002, 77:717.
94. Michel M.C., Beck-Sickinger A., Cox H., et al. XVI. International Union of Pharmacology recommendations for nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 1998, 50:143.
95. Sun L., Philipson L.H., Miller R.J. Regulation of K+ and Ca ++ channels by a family of neuropeptide Y receptors. J Pharmacol Exp Ther 1998, 284:625.
96. Perera A.D., Plant T.M. Ultrastructural studies of neuronal correlates of the pubertal reaugmentation of hypothalamic gonadotropin-releasing hormone (GnRH) release in the rhesus monkey (Macaca mulatta). J Comp Neuro 1997, 385:71.
97. Plant T.M. Gonadotropin-releasing hormone neuron remodeling: causal for puberty onset?. Trends Endocrinol Metab 2007, 18:50.
98. Perera A.D., Lagenaur C.F., Plant T.M. Postnatal expression of polysialic acid-neural cell adhesion molecule in the hypothalamus of the male rhesus monkey (. Macaca mulatta). Endocrinology 1993, 133:2729.
99. Plant T.M. Concluding remarks: Fourth International Conference on the Control of the Onset of Puberty. The Neurobiology of Puberty Bristol 1995, 175. The Journal of Endocrinology Limited Bristol. T.M. Plant, P.A. Lee (Eds.).
100. Ojeda S.R., Lomniczi A., Mastronardi C., et al. Minireview: the neuroendocrine regulation of puberty: is the time ripe for a systems biology approach?. Endocrinology 2006, 147:1166.
101. Plant T.M., Fraser M.O., Medhamurthy R., et al. Somatogenic control of GnRH neuronal synchronization during development in primates: a speculation. Control of the Onset of Puberty 1989, vol 3:111. Elsevier, Amsterdam. H.A. Delemarre van de Waal, T.M. Plant, G.P. van Rees, J. Schoemaker (Eds.).
102. Frisch R.E., Revelle R., Cook S. Components of weight at menarche and the initiation of the adolescent growth spurt in girls: estimated total water, lean body weight and fat. Hum Biol 1973, 45:469.
103. Adair L.S., Gordon-Larsen P. Maturational timing and overweight prevalence in US adolescent girls. Am J Public Health 2001, 91:642.
104. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763.
105. Schwartz M.W., Woods S.C., Porte D., et al. Central nervous system control of food intake. Nature 2000, 404:661.
106. Garcia-Mayor R.V., Andrade A., Rios M., et al. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab 1997, 82:2849.
107. Ahmed M.L., Ong K.K.L., Morrell D.J., et al. Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J Clin Endocrinol Metab 1999, 84:899.
108. Blum W.F., Englaro P., Hanitsch S., et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 1997, 82:2904.
109. Mantzoros C.S., Flier J.S., Rogol A.D. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997, 82:1066.
110. Kratzsch J., Lammert A., Bottner A., et al. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. J Clin Endocrinol Metab 2001, 87:4587.
111. Mann D.R., Johnson A.O.K., Gimpel T., et al. Changes in circulating leptin, leptin receptor, and gonadal hormones from infancy until advanced age in humans. J Clin Endocrinol Metab 2003, 88:3339.
112. Strobel A., Issad I., Camoin L., et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998, 18:213.
113. Farooqi I.S., Jebb S.A., Langmack G., et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999, 341:879.
114. Farooqi I.S. Leptin and the onset of puberty: insights from rodent and human genetics. Semin Reprod Med 2002, 20:139.
115. Witchel S.F., Arslanian S., Lee P.A. Leptin concentrations in precocious puberty or untimely puberty with and without GnRH analogue therapy. J Pediatr Endocrinol Metab 1999, 12:839.
116. Mann D.R., Plant T.M. Leptin and pubertal development in higher primates. Leptin and Reproduction 2003, 133. Kluwer Academic/Plenum Publishers, New York. V.D. Castracane, M.D. Henson (Eds.).
117. Blüher S., Mantzoros C.S. Leptin in reproduction. Curr Opin Endocrinol Diabetes Obesity 2007, 14:458.
118. Kaplowitz P.B. Link between body fat and the timing of puberty. Pediatrics 2008, 121(Suppl 3):S208.
119. Galler A., Schuster V., Kiess W. Pubertal adipose tissue: is it really necessary for normal sexual maturation?. Eur J Endocrinol 2001, 145:807.
120. Andreelli F., Hanaire-Broutin H., Laville M., et al. Normal reproductive function in leptin-deficient patients with lipoatropic diabetes. J Clin Endocrinol Metab 2000, 85:715.
121. Smith J.T., Acohido B.V., Clifton D.K., et al. Kiss-1 neurons are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 2006, 18:298.
122. Marshall W.A., Limongi Y. Skeletal maturity and the prediction of age at menarche. Ann Hum Biol 1976, 3:235.
123. Flor-Cisneros A., Roemmich J.N., Rogol A.D., et al. Bone age and onset of puberty in normal boys. Mol Cell Endocrinol 2006, 254-255:202.
124. Dimeglio A. Growth in pediatric orthopedics. J Pediatr Orthop 2001, 21:549.
125. Styne D.M., Grumbach M.M. Puberty in the male and female: its physiology and disorders. Reproductive Endocrinology 1978, 189. WB Saunders, Philadelphia. S.S.C. Yen, R.B. Jaffe (Eds.).
126. Tanner J.M., Whitehouse R.H. A note on the bone age at which patients with true isolated growth hormone deficiency enter puberty. J Clin Endocrinol Metab 1975, 41:788.
127. Flor-Cisneros A., Leschek E.W., Merke D.P., et al. In boys with abnormal developmental tempo, maturation of the skeleton and the hypohalamic-piuitary-gonadal axis remains synchronous. J Clin Endocrinol Metb 2004, 89:236.
128. Szulc P., Seeman E., Delmas P.D. Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 2000, 11:281.
129. Giustina A., Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998, 19:717.
130. Lofqvist C., Andersson E., Gelander L., et al. Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 2001, 86:5870.
131. Amiel S.A., Sherwin R.S., Simonson D.C., et al. Impaired insulin action in puberty. N Engl J Med 1986, 315:215.
132. Hannon T.S., Janosky J., Arslanian S.A. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 2006, 60:759.
133. Moran A., Jacobs D.R., Steinberger J., et al. Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis. J Clin Endocrinol Metab 2002, 87:4817.
134. Amiel S.A., Caprio S., Sherwin R.S., et al. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991, 72:277.
135. Travers S.H., Jeffers B.W., Bloch C.A., et al. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 1995, 80:172.
136. Ibáñez L., Ong K., Valls C., et al. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006, 91:2888.
137. Ibáñez L., Ong K., Valls C., et al. Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty. J Clin Endocrinol Metab 2006, 91:2068.
138. Dunger D.B., Ahmed M.L., Ong K.K. Early and late wight gain and the timing of puberty. Mol Cel Endocrinol 2006, 254-255:140.
139. Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656.
140. Bellone S., Rapa A., Vivenza D., et al. Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood. J Endocrinol Invest 2002, 25:RC13.
141. Tena-Sempere M. Roles of ghrelin and leptin in the control of reproductive function. Neuroendocrinology 2007, 86:229.
142. Banerjee R.R., Lazar M.A. Resistin: molecular history and prognosis. J Mol Med 2003, 81:218.
143. Stefan N., Stumvoll M. Adiponectin: its role in metabolism and beyond. Horm Metab Res 2002, 34:469.
144. Cell J.S., Carr B.R., Sasano H., et al. Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularis. J Clin Endocrinol Metab 1993, 83:3695.
145. Rainey W.E., Carr B.R., Sasano H., et al. Dissecting human adrenal androgen production. Trends Endocrinol Metab 2002, 13:234.
146. Guercio G., Rivarola M.A., Chaler E., et al. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab 2003, 88:1389.
147. Yanovski J.A., Sovik K.N., Nguyen T.T., et al. Insulin-like growth factors and bone mineral density in African American and white girls. J Pediatr 2000, 137:826.
148. Sklar C.A., Kaplan S.L., Grumbach M.M. Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocinol Metab 1980, 51:548.
149. Remer T., Manz F. Role of nutritional status in the regulation of adrenarche. J Clin Endocrinol Metab 1999, 84:3936.
150. Palmert M.R., Hayden D.L., Mansfiedl M.J., et al. The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 2001, 86:4536.
151. Palmert M.R., Boepple P.A. Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab 2001, 86:2364.
152. Sedlmeyer I.L., Palmert M.R. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab 2002, 87:661.
153. Sedlmeyer I.L., Hirschhorn J.N., Palmert M.R. Pedigree analysis of constitutional delay of growth and maturation: determination of familial aggregation and inheritance patterns. J Clin Endocrinol Metab 2002, 87:5581.
154. de Vries L., Kauschansky A., Shohat M., et al. Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab 2004, 89:1794.
155. Takahashi J.S. Finding new clock components: past and future. J Biol Rhythms 2004, 19:339.
156. Palmert M.R., Hirschhorn J.N. Genetic approaches to stature, pubertal timing, and other complex traits. Mol Genet Metab 2003, 80:1.
157. Kalantaridou S.N., Chrousos G.P. Monogenic disorders of puberty. J Clin Endocrinol Metab 2002, 87:2481.
158. Hardelin J.P. Kallmann syndrome: towards molecular pathogenesis. Mol Cell Endocrinol 2001, 179:75.
159. Murphy S.K., Jirtle R.L. Imprinting evolution and the price of silence. Bioessays 2003, 25:577.
160. Dolinoy D.C., Jirtle R.L. Environmental epigenomics in human health and disease. Environ Mol Mutagen 2008, 49:4.
161. Hanson M.A., Gluckman P.D. Developmental origins of health and disease: new insights. Basic Clin Pharmacol Toxicol 2008, 102:90.
162. Burdge G.C., Hanson M.A., Slater-Jefferies J.L., et al. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life?. Br J Nutr 2007, 97:1036.
163. Bongaart S.J. Does malnutrition affect fecundity? A summary of evidence. Science 1980, 208:564.
164. Frisch RE Weight at menarche: similarity for well-nourished and undernourished girls at differing ages, and evidence for historical constancy. Pediatrics 1972, 50:445.
165. Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics 2002, 110:903.
166. Frisch R.E., Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 1970, 169:397.
167. Cameron J.L. Regulation of reproductive hormone secretion in primates by short-term changes in nutrition. Rev Reprod 1996, 1:117.
168. Kissinger D.G., Sanchez A. The association of dietary factors with the age of menarche. Nutr Res 1987, 7:471.
169. de Ridder C.M., Thijssen J.H.H., Van't Veer P., et al. Dietary habits, sexual maturation, and plasma hormones in pubertal girls: a longitudinal study. Am J Clin Nutr 1991, 54:805.
170. Berkey C.S., Gardner J.D., Frazier A.L., et al. Relation of childhood diet and body size to menarche and adolescent growth in girls. Am J Epidemiol 2000, 152:446.
171. Mazur W., Adlercreutz H. Overview of naturally occurring endocrine-active substances in the human diet in relation to human health. Nutrition 2000, 16:654.
172. Teilmann G., Juul A., Skakkebæk N.E., et al. Putative effects of endocrine disruptors on pubertal development in the human. Best Prac Res Clin Endocrinol Metab 2002, 16:105.
173. Warren M.P., Stiehl A.L. Exercise and female adolescents: effects on the reproductive and skeletal systems. J Am Med Womens Assoc 1999, 54:115.
174. Theintz G.E., Howald H., Allemann Y., et al. Growth and pubertal development of female gymnasts and swimmers: a correlation with parental data. J Sports Med 1980, 10:87.
175. Warren M.P. The effects of exercise on pubertal progression and reproductive function in girls. J Clin Endocrinol Metab 1980, 51:1150.
176. Georgopoulos N., Markou K., Theodoropoulou A., et al. Growth and pubertal development in elite female rhythmic gymnasts. J Clin Endocrinol Metab 1999, 84:4525.
177. Roemmich J.N., Richmond E.J., Rogol A.D. Consequences of sport training during puberty. J Endocrinol Invest 2001, 24:708.
178. Hoffman P.L., Cutfield W.S., Robinson E.M. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997, 82:402.
179. Ibáñez L., Potau N., Francois I., et al. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998, 83:3558.
180. Barker D.J. The Wellcome Foundation Lecture: 1994. The fetal origins of adult disease. Proc R Soc Lond B Biol Sci 1995, 262:37.
181. Francois I., de Zegher F. Adrenarche and fetal growth. Pediatr Res 1997, 41:440.
182. Ibáñez L., Potau N., Marcos M.V., et al. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 1999, 84:4739.
183. Ong K.K., Potau N., Petry C.J., et al. Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab 2004, 89:2647.
184. Ibáñez L., Potau N., Ferrer A., et al. Reduced ovulation rate in adolescent girls born small for gestational age. J Clin Endocrinol Metab 2002, 87:3391.
185. Hokken-Koelega A.C. Timing of puberty and fetal growth. Best Pract Res Clin Endocrinol Metab 2002, 16:65.
186. Persson I., Ahlsson F., Ewald U., et al. Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long term diseases. Am J Epidemiol 1999, 150:747.
187. Leger J., Levy-Marchal C., Bloch J., et al. Reduced final height and indications for insulin resistance in 20-year-olds born small for gestational age: regional cohort study. BMJ 1997, 315:341.
188. Adair L.S. Size at birth predicts age at menarche. Pediatrics 2001, 107:E59.
189. Francois I., de Zegher F., Spiessens C., et al. Low birth weight and subsequent male subfertility. Pediatr Res 1997, 42:899.
190. Mul D., Oostdijk W., Drop S.L. Early puberty in adopted children. Horm Res 2002, 57:1.
191. Parent A.S., Teilmann G., Juul A., et al. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003, 24:668.
192. Teilmann G., Boas M., Petersen J.H., et al. Early pituitary-gonadal activation before clinical signs of puberty in 5- to 8-year-old adopted girls: a study of 99 foreign adopted girls and 93 controls. J Clin Endocrinol Metab 2007, 92:2538.
193. Krstevska-Konstantinova M., Charlier C., Craen M., et al. Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides. Hum Reprod 2001, 16:1020.
194. Brito V.N., Batista M.C., Borges M.F., et al. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 1999, 84:3539.
195. Partsch C.-J., Heger S., Sippell W.G. Management and outcome of central precocious puberty. Clin Endocrinol 2002, 56:129.
196. Cisternino M., Arrigo T., Pasquino A.M., et al. Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab 2000, 13(Suppl 1):695.
197. Jung H., Ojeda S.R. Pathogenesis of precocious puberty in hypothalamic hamartoma. Horm Res 2002, 57(Suppl 2):31.
198. Parent A.S., Matagne V., Westphal M., et al. Gene expression profiling of hypothalamic hamartomas: a search for genes associated with central precocious puberty. Horm Res 2008, 6:114.
199. Adan L., Bussieres L., Dinand V. Growth, puberty and hypothalamic-pituitary function in children with suprasellar arachnoid cyst. Eur J Pediatr 2000, 159:348.
200. Setian N., Andrade R.S., Kuperman H., et al. Precocious puberty: an endocrine manifestation in congenital toxoplasmosis. J Pediatr Endocrinol Metab 2002, 15:1487.
201. Siddiqi S.U., Van Dyke D.C., Donohoue P., et al. Premature sexual development in individuals with neurodevelopmental disabilities. Dev Med Child Neurol 1999, 41:392.
202. Trivin C., Couto-Silva A.C., Sainte-Rose C., et al. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion. Clin Endocrinol (Oxf) 2006, 65:239.
203. Ojeda S.R., Heger S. New thoughts on female precocious puberty. J Pediatr Endocrinol Metab 2001, 14:245.
204. Cherniske E.M., Sadler L.S., Schwartz D. Early puberty in Williams syndrome. Clin Dysmorphol 1999, 8:117.
205. Municchi G., Marconcini S., D'Ambrosio A., et al. Central precocious puberty in multisystem Langerhans cell histiocytosis: a case report. Pediatr Hematol Oncol 2002, 19:273.
206. Hordijk R., Wierenga H., Scheffer H., et al. Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype. J Med Genet 1999, 36:782.
207. Buiting K., Kanber D., Martín-Subero J.I., et al. Clinical features of maternal uniparental disomy 14 in patients with an epimutation and a deletion of the imprinted DLK1/GTL2 gene cluster. Hum Mutat 2008, 29(9):1141.
208. Belgorosky A., Rivarola M.A. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty. Horm Res 1998, 49:226.
209. Eugster E.A., Clarke W., Kletter G.B., et al. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial. J Clin Endocrinol Metab 2007, 92:1697.
210. Van der Sluis I.M., Boot A.M., Krenning E.P., et al. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during, and after cessation of GnRH agonist therapy. J Clin Endocrinol Metab 2002, 87:506.
211. Witchel S.F., Baens-Bailon R.G., Lee P.A. Treatment of central precocious puberty: comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy. J Clin Endocrinol Metab 1996, 81:1353.
212. Klein K.O., Barnes K.M., Jones J.V., et al. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001, 86:4711.
213. Mul D., Oostdijk W., Otten B.J., et al. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab 2000, 13(Suppl l):765.
214. Tanaka T., Niimi H., Matsuo N., et al. Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty. J Clin Endocrinol Metab 2005, 90:1371.
215. Heger S., Müller M., Ranke M., et al. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Mol Cell Endocrinol 2006, 254-255:217.
216. Pasquino A.M., Pucarelli I., Accardo F., et al. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function. J Clin Endocrinol Metab 2008, 93:190.
217. Palmert T., Malin H.V., Boepple P.A. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab 1999, 84:415.
218. Leger J., Reynaud R., Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?. J Pediatr 2000, 137:819.
219. Lazar L., Pertzelan A., Weintrob N., et al. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-sup-pressive therapy and final height. J Clin Endocrinol Metab 2001, 86:4127.
220. Weinstein L.S., Shenker A., Gejman P.V., et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991, 325:1688.
221. Coutant R., Lumbroso S., Rey R., et al. Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab 2001, 86:1778.
222. Lumbroso S., Paris F., Sultan C. European Collaborative Study. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome-a European Collaborative Study. J Clin Endocrinol Metab 2004, 89:2107.
223. Feuillan P., Merke D., Leschek E.W., et al. Use of aromatase inhibitors in precocious puberty. Endocr Rel Cancer 1999, 6:303.
224. Eugster E.A., Shankar R., Feezle L.K., et al. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome. J Pediatr Endocrinol 1999, 12:681.
225. Mieszczak J, Lowe ES, Plourde P, et al. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 93(7):2751.
226. Laven J.S., Lumbroso S., Sultan C., et al. Dynamics of ovarian function in an adult woman with McCune-Albright syndrome. J Clin Endocrinol Metab 2001, 86:2625.
227. Riminucci M., Liu B., Corsi A., et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs? gene, site-specific patterns and recurrent histological hallmarks. J Pathol 1999, 187:249.
228. Lala R., Matarazzo P., Bertelloni S., et al. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 2000, 89:188.
229. Isaia G.C., Lala R., Defilippi C., et al. Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia. Calcif Tissue Int 2002, 71:121.
230. Cronje H.S., Niemand I., Bam R.H., et al. Granulosa and theca cell tumors in children: a report of 17 cases and literature review. Obstet Gynecol Surv 1998, 53:240.
231. Duke D.S., Yoo E.Y., Newton C., et al. A rare cause of vaginal bleeding in a 7-month-old female infant. J Pediatr Surg 2008, 43:E1.
232. Rey R., Sabourin J.C., Venara M., et al. Anti-mullerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol 2000, 31:1202.
233. Silverman L.A., Gitelman S.E. Immunoreactive inhibin, mullerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumours. J Pediatr 1996, 129:918.
234. Choong C.S., Fuller P.J., Chu S., et al. Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant. J Clin Endocrinol Metab 2002, 87:49.
235. Lin C.J., Jorge A.A.L., Latronico A.C., et al. Origin of an ovarian steroid cell tumor causing isosexual pseudoprecocious puberty demonstrated by the expression of adrenal steroidogenic enzymes and adrenocorticotropin receptor. J Clin Endocrinol Metab 2000, 85:1211.
236. Herd M.C., Wiebel J., Schafer H., et al. Feminizing Sertoli cell tumors associated with Peutz-Jeghers syndrome: an increasingly recognized cause of prepubertal gynecomastia. Plast Reconstr Surg 1998, 102:1151.
237. Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 1999, 55:735.
238. Resta N., Stella A., Susca F.C., et al. Two novel mutations and a new STK11/LKB1 gene isoform in Peutz-Jeghers patients. Hum Mutat 2002, 20:78.
239. Zayed A., Stock J.L., Liepman M.K., et al. Feminization as a result of both peripheral conversion of androgens and direct estrogen production from an adrenocortical carcinoma. J Endocrinol Invest 1994, 17:275.
240. Watanabe T., Yasuda T., Noda H., et al. Estrogen secreting adrenal adenocarcinoma in an 18-month-old boy: aromatase activity, protein expression, mRNA, and utilization of gonadal type promoter. Endocr J 2000, 47:723.
241. Agarwal V.R., Takayama K., Van Wyk J.J., et al. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab 1998, 83:1797.
242. Lazala C., Saenger P. Pubertal gynecomastia. J Pediatr Endocrinol Metab 2002, 15:553.
243. Stratakis C.A., Vottero A., Brodie A., et al. The aromatase excess syndrome is associated with feminization in both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab 1998, 83:1348.
244. Demura M., Martin R.M., Shozu M., et al. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene. Hum Mol Genet 2007, 16:2529.
245. Garcia C.J., Espinoza A., Dinamarca V., et al. Breast US in children and adolescents. Radiographics 2000, 20:1605.
246. Klein K.O., Mericq V., Brown-Dawson J.M., et al. Estrogen levels in girls with premature thelarche compared with normal prepubertal girls as determined by an ultrasensitive recombinant cell bioassay. J Pediatr 1999, 134:190.
247. Mills J.L. Premature thelarche: natural history and etiologic investigation. Am J Dis Child 1981, 135:743.
248. Van Winter J.T., Noller K.L., Zimmerman D., et al. Natural history of premature thelarche in Olmsted County, Minnesota, 1940 to 1984. J Pediatr 1990, 116:278.
249. Salardi S., Cacciari E., Mainetti B., et al. Outcome of premature thelarche: relation to puberty and final height. Arch Dis Child 1998, 79:173.
250. Bereket A., Turan S., Alper G., et al. Two patients with Kabuki syndrome presenting with endocrine problems. J Pediatr Endocrinol Metab 2001, 14:215.
251. Pringle P.J., Stanhope R., Hindmarsh P., et al. Abnormal pubertal development in primary hypothyroidism. Clin Endocrinol (Oxf) 1988, 28:479.
252. Van Wyk J.J., Grumbach M.M. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap in pituitary feedback. J Pediatr 1960, 57:416.
253. Gordon C.M., Austin D.J., Radovick S., et al. Primary hypothyroidism presenting as severe vaginal bleeding in a prepubertal girl. J Pediatr Adolesc Gynecol 1997, 10:35.
254. Riddlesberger M.M., Kuhn J.P., Munschauer R.W. The association of juvenile hypothyroidism and cystic ovaries. Radiology 1981, 139:77.
255. Browne L.P., Boswell H.B., Crotty E.J., et al. Van Wyk and Grumbach syndrome revisited: imaging and clinical findings in pre- and postpubertal girls. Pediatr Radiol 2008, 38:538.
256. Anasti J.N., Flack M.R., Froehlich J., et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995, 80:276.
257. Castro-Magaña M., Angulo M., Cañas A., et al. Hypothalamic-pituitary gonadal axis in boys with primary hypothyroidism and macroorchidism. J Pediatr 1998, 112:397.
258. Jannini E.A., Ulisse S. Thyroid hormone and male gonadal function. Endocr Rev 1995, 16:443.
259. Marshall G.R., Plant T.M. Puberty occurring either spontaneously or induced precociously in rhesus monkey (Macaca mulatta) is associated with a marked proliferation of Sertoli cells. Biol Reprod 1996, 54:1192.
260. Walker W.H. Molecular mechanisms controlling Sertoli cell proliferation and differentiation. Endocrinology 2003, 144:3719.
261. Mann D.R., Bhat G.K., Stah C.D., et al. Induction of a hypothyroid state during juvenile development delays pubertal reactivation of the neuroendocrine system governing luteinizing hormone secretion in the male rhesus monkey (Macaca mulatta). J Neuroendocrinol 2006, 18:662.
262. Colon I., Caro D., Bourdony C.J., et al. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 2000, 108:895.
263. Massart F., Meucci V., Saggese G., et al. High growth rate of girls with precocious puberty exposed to estrogenic mycotoxins. J Pediatr 2008, 152:690.
264. Miller J.D. Aspects of the ecology of Fusarium toxins in cereals. Adv Exp Med Biol 2002, 504:19.
265. Ibáñez L Ong K., De Zegher F., et al. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinemia and androgenemia from prepuberty to post-menarche. Clin Endocrinol 2003, 58:372.
266. Ibáñez L., Virdis R., Potau N., et al. Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab 1992, 74:254.
267. Ibáñez L., Potau N., Zampolli M., et al. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1977, 82:2283.
268. Ibáñez L., Potau N., Chacon P., et al. Hyperinsulinemia, dysplipemia, and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998, 41:1057.
269. Palmert M.R., Gordon C.M., Kartashov A.I., et al. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:1017.
270. Witchel S.F., Lee P.A., Suda-Hartman M., et al. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med 1997, 62:151.
271. Witchel S.F., White C., Siegel M.E., et al. Inconsistent effects of the proline12 ? alanine variant of the peroxisome proliferator-activated receptor-?2 gene on body mass index in children and adolescent girls. Fertil Steril 2001, 76:741.
272. Ibanez L., Marcos My Potau N., et al. Increased frequency of the G972R variant of the insulin receptor substrate-1 (IRS-1) gene among girls with a history of precocious pubarche. Fertil Steril 2002, 78:1288.
273. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393.
274. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343.
275. White P.C., Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000, 21:245.
276. Miller W.L. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994, 78:241.
277. White P.C., Curnow K.M., Pascoe L. Disorders of steroid ll?-hydroxylase isozymes. Endocr Rev 1994, 15:421.
278. Bristow J., Tee M.K., Gitelman S.E., et al. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21. J Cell Biol 1993, 122:265.
279. Menassa R., Tardy V., Despert F., et al. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab 2008, 93:1901.
280. Speiser P.W., Dupont J., Zhu D., et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxy-lase deficiency. J Clin Invest 1992, 90:584.
281. Wedell A., Ritzen E.M., Haglund-Stengler B., et al. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci U S A 1992, 89:7232.
282. Siegel S.F., Lee P.A., Rudert W.A., et al. Phenotype/genotype correlations in 21-hydroxylase deficiency. Adolesc Pediatr Gynecol 1995, 8:9.
283. Rumsby G., Avey C.J., Conway G.S., et al. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms. Clin Endocrinol 1998, 48:707.
284. Chin D., Speiser P.W., Imperato-McGinley J., et al. Study of a kindred with classic congenital adrenal hyperplasia: diagnostic challenge due to phenotypic variance. J Clin Endocrinol Metab 1998, 83:1940.
285. Wilson R.C., Mercado A.B., Cheng K.C., et al. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995, 80:2322.
286. Jaaskelainen J., Levo A., Voutilainen R., et al. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well-defined population. J Clin Endocrinol Metab 1997, 82:3293.
287. Nikoshkov A., Lajic S., Holst M., et al. Synergistic effects of partially inactivating mutations in steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1997, 82:194.
288. Moisan A.M., Ricketts M.L., Tardy V., et al. New insights into the molecular basis of 3?-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3?II gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J Clin Endocrinol Metab 1999, 84:4410.
289. Rheaume E., Simard J., Morel Y., et al. Congenital adrenal hyperplasia due to point mutations in the type II 3?-hydroxysteroid dehydrogenase gene. Nat Genet 1992, 1:239.
290. Simard J., Rheaume E., Sanchez R., et al. Molecular basis of congenital adrenal hyperplasia due to 3?-hydroxysteroid dehydrogenase deficiency. Mol Endocrinol 1993, 7:716.
291. Sanchez R., Mebarki F., Rhéaume E., et al. Functional characterization of the novel L108W and P186L mutations detected in the type II 3?-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia. Hum Mol Genet 1994, 3:1639.
292. Zerah M., Rhéaume E., Mani P., et al. No evidence of mutations in the genes for type I and type II 3?-hydroxysteroid dehydrogenase (3?- HSD) in nonclassical 3?-HSD deficiency. J Clin Endocrinol Metab 1994, 79:1811.
293. Chang Y.T., Zhang L., Alkaddour H.S., et al. Absence of molecular defect in the type II 3?-hydroxysteroid dehydrogenase deficiency (3?-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3?-HSD activity. Pediatr Res 1995, 37:820.
294. Tajima T., Nishi Y., Takase A., et al. No genetic mutation in type II 3?-hydroxysteroid dehydrogenase gene in patients with biochemical evidence of enzyme deficiency. Horm Res 1997, 47:49.
295. Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11?-hydroxylase deficiency: a study of 25 patients. J Clin Endocrinol Metab 56:222, 183.
296. Rosler A., Leiberman E., Cohen T. High frequency of congenital adrenal hyperplasia (classic 11?-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet 1992, 42:827.
297. Miller W.L. P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations. Trends Endocrinol Metab 2004, 15:311.
298. Scott R.R., Miller W.L. Genetic and clinical features of P450 oxidoreductase deficiency. Horm Res 2008, 69:266.
299. Arlt W. P450 oxidoreductase deficiency and Antley-Bixler syndrome. Rev Endocr Metab Disord 2007, 8:301.
300. Flück C.E., Tajima T., Pandey A.V., et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004, 36:228.
301. Huang N., Pandey A.V., Agrawal V., et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 2005, 76:729.
302. Witchel S.F., Lee P.A. Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests. Am J Med Genet 1998, 76:337.
303. Lutfallah C., Wang W., Mason J.I., et al. Newly proposed hormonal criteria via genotypic proof for type II 3?-hydroxysteroid dehydro-genase deficiency. J Clin Endocrinol Metab 2002, 87:2611.
304. Merke D.P. Approach to the adult with congenital adrenal hyperplasia due to 21- hydroxylase deficiency. J Clin Endocrinol Metab 2008, 93:653.
305. Punthakee Z., Legault L., Polychronakos C. Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. J Pediatr 2003, 143:402.
306. Riepe F.G., Sippell W.G. Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Rev Endocr Metab Disord 2007, 8:349.
307. Lee P.A., Witchel S.F. Genital surgery among females with congenital adrenal hyperplasia: changes over the past five decades. J Pediatr Endocrinol Metab 2002, 15:1473.
308. Kuhnle U., Bullinger M. Outcome of congenital adrenal hyperplasia. Pediatr Surg Int 1997, 12:511.
309. Berenbaum S.A. Effects of early androgens on sex-typed activities and interests in adolescents with congenital adrenal hyperplasia. Horm Behav 1999, 35:102.
310. Berenbaum S.A., Bailey J.M. Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2003, 88:1102.
311. Migeon C.J., Wisniewski A.B., Gearhart J.P., et al. Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome. Pediatrics 2002, 110:e31.
312. Slijper F.M.E., Frets P.G., Boehmer A.L.M., et al. Androgen insensitivity syndrome (AIS): emotional reactions of parents and adult patients to the clinical diagnosis of AIS and its confirmation by androgen receptor mutation analysis. Horm Res 2000, 52:9.
313. Migeon C.J., Wisniewski A.B., Brown TR, et al. 46,XY intersex individuals, phenotypic and etiologic classification, knowledge of condition, and satisfaction with knowledge in adulthood. Pediatrics 2002, 110:e32.
314. Charmandari E., Kino T., Ichijo T. Chrousos GP.Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 2008, 93:1563.
315. Shenker A., Laue L., Kosugi S., et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993, 365:652.
316. Latronico A.C., Abell A.N., Arnhold I.J., et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 1998, 83:2435.
317. Shinozaki H., Fanelli F., Liu X., et al. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness. Mol Endocrinol 2001, 15:972.
318. Leschke E.W., Jones J., Barnes K.M., et al. Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. J Clin Endocrinol Metab 1999, 84:175.
319. Soriano-Guillén L., Lahlou N., Chauvet G., et al. Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty. J Clin Endocrinol Metab 2005, 90:147.
320. Almeida M.Q., Brito V.N., Lins T.S., et al. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clin Endocrinol (Oxf) 2008, 69:93.
321. Rosenthal I.M., Refetoff S., Rich B., et al. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor: a clinical research center study. J Clin Endocrinol Metab 1996, 81:3802.
322. Solish S.B., Goldsmith M.A., Voutilainen R., et al. Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia. J Clin Endocrinol Metab 1989, 69:1148.
323. Liu G., Duranteau L., Carel J.C., et al. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 1999, 341:1731.
324. Vieira T.C., Cerutti J.M., Dias da Silva M.R., et al. Absence of activating mutations in the hot spots of the LH receptor and Gs-alpha genes in Leydig cell tumors. J Endocrinol Invest 2002, 25:598.
325. Smith D., Crotty T.B., Murphy J.F., et al. A steroid cell tumor outside the ovary is a rare cause of virilization. Fertil Steril 2006, 85:227.
326. Starzyk J., Starzyk B., Bartnik-Mikuta A., et al. Gonadotropin releasing hormone-independent precocious puberty in a 5-year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein. J Pediatr Endocrinol Metab 2001, 14:789.
327. Michalkiewicz E., Sandrini R., Figueiredo B., et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 2004, 22:838.
328. Ribeiro R.C., Sandrini F., Figueiredo B., et al. An inherited p 53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 2001, 98:9330.
329. Stratakis C.A., Boikos S.A. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab 2007, 3:748.
330. Pescovitz OH, Hench KD, Barnes KM, et al. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 67:474, 2018.
331. Bhatia S., Neely E.K., Wilson D.M. Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy. Pediatrics 2002, 109:E30.
332. Resende E.A., Lara B.H., Reis J.D., et al. Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab 2007, 92:1424.
333. de Vries L., Horev G., Schwartz M., et al. Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche. Eur J Endocrinol 2006, 154:891.
334. Perry R.J., Findlay C.A., Donaldson M.D. Cushing's syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Child 2002, 87:45.
335. Reiter E.O., Lee P.A. Delayed puberty: state of the art reviews. Adolesc Endocrinol 2002, 13:101.
336. Sedlmeyer I.L., Palmert M.R. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab 2002, 87:1613.
337. Hay C., Wu F. Genetics and hypogonadotropic hypogonadism. Curr Opin Obstet Gynecol 2002, 14:303.
338. Franco B., Guioli S., Pragliola A., et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991, 353:529.
339. Legouis R., Hardelin J., Levilliers J., et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991, 67:423.
340. Hardelin J.P., Levilliers J., Blanchard S., et al. Heterogeneity in the mutations responsible for the X-chromosome-linked Kallmann syndrome. Hum Mol Genet 1993, 2:373.
341. Oliveira L.M.B., Seminara S.B., Beranova M., et al. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocr Metab 2001, 86:1532.
342. Pitteloud N., Hayes F.J., Boepple P.A., et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2002, 87:152.
343. Massin N., Pêcheux C., Eloit C., et al. X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene. J Clin Endocrinol Metab 2003, 88(5):2003.
344. Dode C., Levilliers J., Dupont J.-M., et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003, 33:1.
345. Salenave S., Chanson P., Bry H., et al. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. J Clin Endocrinol Metab 2008, 93:758.
346. Pitteloud N., Meysing A., Quinton R., et al. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol 2006, 60. 254-255.
347. Seminara S.B., Acierno J.S., Abdulwahid N.A., et al. Hypogonadotropic hypogonadism and cerebellar ataxia: detailed phenotypic characterization of a large, extended pedigree. J Clin Endocrinol Metab 2002, 87:1607.
348. Pitteloud N., Zhang C., Pignatelli D., et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A 2007, 104:17447.
349. Dodé C., Teixeira L., Levilliers J., et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006, 2:e175.
350. Pitteloud N., Quinton R., Pearce S., et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 2007, 117:457.
351. Raivio T., Falardeau J., Dwyer A., et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 2007, 357:863.
352. Ribeiro R.S., Vieira T.C., Abucham J. Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review. Eur J Endocrinol 2007, 156:285.
353. Bhasin S. Experiments of nature: a glimpse into the mysteries of the pubertal clock. N Engl J Med 2007, 357:929.
354. Støving R.K., Hangaard J., Hansen-Nord M., et al. A review of endocrine changes in anorexia nervosa. J Psychiatry Res 1999, 33:139.
355. Rogol A.D. Androgens and puberty. Mol Cell Endocrinol 2002, 198:25.
356. Welt C.K., Chan J.L., Bullen J., et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004, 351:987.
357. Montague C.T., Farooqi I.S., Whitehead J.P., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387:903.
358. Clement K., Vaisse C., Lahlou N., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392:398.
359. Beranova M., Oliveira L.M.B., Bedecarrats G.Y., et al. Prevalence, phenotypic spectrum, and modes of inheritance of GnRH receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2001, 86:1580.
360. Bédécarrats G.Y., Kaiser U.B. Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function. Semin Reprod Med 2007, 25:368.
361. De Roux N., Young J., Brailly-Tabard S., et al. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J Clin Endocrinol Metab 1999, 84:567.
362. Karges B., Karges W., Mine M., et al. Mutation Alal71Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2003, 88:1873.
363. Leanos-Miranda A., Janovick J.A., Conn P.M. Receptor-misrouting:an unexpected prevalent and rescuable etiology in GnRHR-mediated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2002, 87:4825.
364. Matthews C.H., Borgato S., Beck-Peccoz P., et al. Primary amenorrhea and infertility due to a mutation in the ?-subunit of follicle-stimulating hormone. Nat Genet 1993, 5:83.
365. Layman L.C., Lee E.J., Peak D.B., et al. Delayed puberty and hypogonadism caused by a mutation in the follicle stimulating hormone ?-subunitgene. N Engl J Med 1997, 337:607.
366. Phillip M., Arbelle J.E., Segev Y., et al. Male hypogonadism due to a mutation in the gene for the ?-subunit of follicle stimulating hormone. N Engl J Med 1998, 338:1729.
367. Lindstedt G., Nystrom E., Matthews C., et al. Follitropin (FSH) deficiency in an infertile male due to FSH? gene mutation: a syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH, but high luteotropin and normal serum testosterone concentrations. Clin Chem Lab Med 1998, 36:663.
368. Layman L.C., Porto A.L.A., Xie J., et al. FSH? gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J Clin Endocrinol Metab 2002, 87:3702.
369. Kalantaridou S.N., Chrousos G.P. Monogenic disorders of puberty. J Clin Endocrinol Metab 2002, 87:2481.
370. Weiss J., Axelrod L., Whitcomb R.W., et al. Hypogonadism caused by a single amino acid substitution in the ?-subunit of luteinizing hormone. N Engl J Med 1992, 326:179.
371. Ramanujam L.N., Liao W.-X., Roy A.C., et al. Association of molecular variants of luteinizing hormone with male infertility. Hum Reprod 2000, 15:925.
372. Liao W.X., Goh H.H., Roy A.C. Functional characterization of a natural variant of luteinizing hormone. Hum Genet 2002, 111:219.
373. Lofrano-Porto A., Barra G.B., Giacomini L.A., et al. Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med 2007, 357:897.
374. Nilsson C., Jiang M., Pettersson K. et al. Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol 1998, 49:369.
375. Jiang M., Pakarinen P., Zhang F.P., et al. A common polymorphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence. Hum Mol Genet 1999, 8:2037.
376. Manna P.R., Joshi L., Reinhold V.N., et al. Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone. Hum Mol Genet 2002, 11:301.
377. Raivio T., Huhtaniemi I., Anttila R, et al. The role of luteinzing hormone-beta gene polymorphism in the onset and progression of puberty in healthy boys. J Clin Endocrinol Metab 1996, 81:3278.
378. Tajima T., Hattorri T., Nakajima T., et al. Sporadic heterozygous frameshift mutations of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patients. J Clin Endocrinol Metab 2003, 88:45.
379. Netchine I., Sobrier M.L., Krude H., et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000, 25:182.
380. Wu W., Cogan J.D., Pfaffle R.W., et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998, 18:147.
381. Vallette-Kasic S., Barlier A., Teinturier C., et al. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001, 86:4529.
382. Pernasetti F., Toledo S.P., Vasilyev V.V., et al. Impairedadrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. J Clin Endocrinol Metab 2000, 85:390.
383. Fluck C., Deladoey J., Rutishauser K., et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg?Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998, 83:3727.
384. Dominguez R., Aguirre Vila-Coro A., Slopis J.M., et al. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 1991, 145:688.
385. McMahon C.L., Braddock S.R. Septo-optic dysplasia as a manifestation of valproic acid embryopathy. Teratology 2001, 64:83.
386. Lubinsky M.S. Hypothesis: septo-optic dysplasia is a vascular disruption sequence. Am J Med Genet 1997, 69:235.
387. Muscatelli F., Strom T.M., Walker A.P., et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994, 372:672.
388. Mantovani G., Ozisik G., Achermann J.C., et al. Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab 2002, 87:44.
389. Achermann J.C., Gu W.X., Kotlar T.J., et al. Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. J Clin Endocrinol Metab 1999, 84:4497.
390. Merke D.P., Tajima T., Baron J., et al. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX-1 gene. N Engl J Med 1999, 430:1248.
391. Achermann J.C., Ito M., Silverman B.L., et al. Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression. J Clin Endocrinol Metab 2001, 86:3171.
392. Lehmann S.G., Wurtz J.-M., Renaud J.-P., et al. Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients. Hum Mol Genet 2003, 12:1063.
393. Calliari L.E., Longui C.A., Rocha M.N., et al. A novel mutation in DAX1 gene causing different phenotypes in three siblings with adrenal hypoplasia congenita. Genet Mol Res 2007, 6:177.
394. Lipscombe L., Asa S.L., Ezzat S. Management of lesions of the pituitary stalk and hypothalamus. Endocrinologist 2003, 13:38.
395. Rashidi M., DaSilva V.R., Minagar A., et al. Nonmalignant pediatric brain tumors. Curr Neurol Neuroscience Rep 2003, 3:200.
396. Makras P., Alexandraki K.I., Chrousos G.P., et al. Endocrine manifestations in Langerhans cell histiocytosis. Trends Endocrinol Metab 2007, 18:252.
397. McNeilly A.S. Suckling and the control of gonadotropin secretion. The Physiology of Reproduction 1994, 1179. Raven Press, New York. ed 2. E. Knobil, J.D. Neill (Eds.).
398. Wand G.S. Diagnosis and management of hyperprolactinemia. Endocrinologist 2003, 13:52.
399. Vanderpump M.P., French J.M., Appleton D., et al. The prevalence of hyperprolactinemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort. Clin Endocrinol 1998, 48:39.
400. Gillam M.P., Middler S., Freed D.J., et al. The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 2002, 87:4447.
401. Achermann J.C., Ito M., Ito M., et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 1999, 22:125.
402. Biason-Lauber A., Schoenle E.J. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 2000, 67:1563.
403. Köhler B., Lin L., Ferraz-de-Souza B., et al. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency. Hum Mutat 2008, 29:59.
404. Lin L., Philibert P., Ferraz-de-Souza B., et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab 2007, 92:991.
405. Crino A., Schiaffini R., Ciampalini P., et al. Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr 2003, 162:327.
406. Gallagher R.C., Pils B., Albalwi M., et al. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet 2002, 71:669.
407. Goldstone A.P. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 2004, 15:12.
408. David A., Bitoun P., Lacombe D., et al. Hydrometrocolpos and poly-dactyly: a common neonatal presentation of Bardet-Biedl and McKusick-Kaufman syndromes. J Med Genet 1999, 36:599.
409. Katsanis N., Ansley S.J., Badano J.L., et al. Triallelic inheritance in Bardet-Biedl syndrome, a mendelian recessive disorder. Science 2001, 293:2256.
410. Hearn T., Renforth G.L., Spalluto C., et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat Genet 2002, 31:79.
411. Collin G.B., Marshall J.D., Ikeda A., et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet 2002, 31:74.
412. Maffei P., Boschetti M., Marshall J.D., et al. Characterization of the IGF system in 15 patients with Alström syndrome. Clin Endocrinol (Oxf) 2007, 66:269.
413. De Gobbi M., Roetto A., Piperno A., et al. Natural history of juvenile haemochromatosis. Br J Haematol 2002, 117:973.
414. Hook E.B., Warburton D. The distribution of chromosomal genotypes associated with Turner syndrome: live-born prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet 1983, 64:24.
415. Davenport M.L., Punyasavatsut N., Stewart P.W., et al. Growth failure in early life: an important manifestation of Turner syndrome. Horm Res 2002, 57:157.
416. Saenger P., Albertsson Wikland K., Conway G.S., et al. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001, 86:3061.
417. Rao E., Weiss B., Fukami M., et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997, 16:54.
418. Lippe B.M., Saenger P.H. Turner syndrome. Pediatric Endocrinology 2002, 519. WB Saunders, Philadelphia. ed 2. M.A. Sperling (Ed.).
419. Gravholt C.H., Lauridsen A.L., Brixen K., et al. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: a cross-sectional study. J Clin Endocrinol Metab 2002, 87:2798.
420. Held K.R., Kerber S., Kaminsky E., et al. Mosaicism in 45,X Turner syndrome: does survival in early pregnancy depend on the presence of two sex chromosomes?. Hum Genet 1992, 88:288.
421. Fernandez-Garcia R., Garcia-Doval S., Costoya S., et al. Analysis of sex chromosome aneuploidy in 41 patients with Turner syndrome: a study of "hidden" mosaicism. Clin Genet 2000, 58:201.
422. Kocova M., Siegel S.F., Wenger S.L., et al. Detection of Y chromosome sequences in Turner syndrome by Southern blot analysis of amplified DNA. Lancet 1993, 342:140.
423. Gravhold C.H., Fedder J., Naeraa R.W., et al. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 2000, 85:3199.
424. Ross J.L., Roeltgen D., Kushner H., et al. The Turner syndrome-associated neurocognitive phenotype maps to distal Xp. Am J Hum Genet 2000, 67:672.
425. Romans S.M., Stefanatos G., Roeltgen D.P., et al. Transition to young adulthood in Ullrich-Turner syndrome: neurodevelopmental changes. Am J Med Genet 1998, 79:140.
426. Migeon B.R., Luo S., Jani M., et al. The severe phenotype of females with tiny ring X chromosome is associated with inability of these chromosome to undergo X inactivation. Am J Hum Genet 1994, 55:497.
427. Bondy C.A. Turner Syndrome Study Group. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007, 92:10.
428. Paterson W.F., Hollman A.S., Donaldson M.D. Poor uterine development in Turner syndrome. Clin Endocrinol 2002, 56:359.
429. Quigley C.A., Crowe B.J., Anglin D.G., et al. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 2002, 87:2033.
430. Bonamico M., Pasquino A.M., Mariani P., et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab 2002, 87:5495.
431. Matura L.A., Ho V.B., Rosing D.R., et al. Aortic dilatation and dissection in Turner syndrome. Circulation 2007, 116:1663.
432. Michala L., Goswami D., Creighton S.M., et al. Swyer syndrome: presentation and outcomes. BJOG 2008, 115:737.
433. Uehara S., Funato T., Yaegashi N., et al. SRY mutation and tumor formation on the gonads of XY pure gonadal dysgenesis patients. Cancer Genet Cytogenet 1999, 113:78.
434. Zieliñska D., Zajaczek S., Rzepka-Górska I. Tumors of dysgenetic gonads in Swyer syndrome. J Pediatr Surg 2007, 42:1721.
435. Mitchell C.L., Harley V.R. Biochemical defects in eight SRY missense mutations causing XY gonadal dysgenesis. Mol Genet Metab 2002, 77:217.
436. Jordan B.K., Jain M., Natarajan S., et al. Familial mutation in the testis-determining gene SRY shared by an XY female and her normal father. J Clin Endocrinol Metab 2002, 87:3428.
437. Pelletier J., Bruening W., Kashtan C.E., et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991, 67:437.
438. Barbaux S., Niaudet P., Gubler M.C., et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997, 17:467.
439. Krob G., Braun A., Kuhnle U. True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology. Eur J Pediatr 1994, 153:2.
440. Wagner T., Wirth J., Meyer J., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79:1111.
441. Savarirayan R., Robertson S.P., Bankier A., et al. Variable expression of campomelic dysplasia in a father and his 46,XY daughter. Pediatr Pathol Mol Med 2003, 22:37.
442. Margarit E., Soler A., Carrio A., et al. Molecular, cytogenetic, and clinical characterisation of six XX males including one prenatal diagnosis. J Med Genet 1998, 35:727.
443. Boucekkine C., Toublanc J.E., Abbas N., et al. Clinical and anatomical spectrum in XX sex-reversed patients: relationship to the presence of Y specific DNA-sequences. Clin Endocrinol (Oxf) 1994, 40:733.
444. Bojesen A., Juul S., Gravholt C.H. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab 2003, 88:622.
445. Madgar I., Dor J., Weissenberg R., et al. Prognostic value of the clinical and laboratory evaluation in patients with nonmosaic Klinefelter syndrome who are receiving assisted reproductive therapy. Fertil Steril 2002, 77:1167.
446. Christiansen P., Andersson A.M., Skakkebaek N.E. Longitudinal studies of inhibin B levels in boys and young adults with Klinefelter syndrome. J Clin Endocrinol Metab 2003, 88:888.
447. Khalifa M.M., Struthers J.L. Klinefelter syndrome is a common cause for mental retardation of unknown etiology among prepubertal males. Clin Genet 2002, 61:49.
448. Rovet J., Netley C., Keenan M., et al. The psychoeducational profile of boys with Klinefelter syndrome. J Learn Disabil 1996, 29:180.
449. Zeger M.P., Zinn A.R., Lahlou N., et al. Effect of ascertainment and genetic features on the phenotype of Klinefelter syndrome. J Pediatr 2008, 152:716.
450. Spires S.E., Woolums S., Pulito A.R., et al. Testicular regression syndrome: a clinical and pathological study of 11 cases. Arch Pathol Lab Med 2000, 124:694.
451. Philibert P., Zenaty D., Lin L., et al. Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod 2007, 22:3255.
452. Maclaren N., Chen Q.Y., Kukreja A., et al. Autoimmune hypogonadism as part of an autoimmune polyglandular syndrome. J Soc Gynecol Invest 2001, 8(1 Suppl Proceedings):S52.
453. Arif S., Vallian S., Farzaneh F., et al. Identification of 3-beta-hydrox-ysteroid dehydrogenase as a novel target of steroid cell autoanti-bodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996, 81:4439.
454. Luborsky J., Llanes B., Roussev R., et al. Ovarian antibodies, FSH, and inhibin B independent markers associated with unexplained infertility. Hum Reprod 2000, 15:1046.
455. van der Burgt I. Noonan syndrome. Orphanet J Rare Dis 2007, 2:4.
456. Tartaglia M., Kalidas K., Shaw A., et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002, 70:1555.
457. Noordam K. Expanding the genetic spectrum of Noonan syndrome. Horm Res 2007, 68:24.
458. Sasagawa I., Nakada T., Kubota Y., et al. Gonadal function and testicular histology in Noonan's syndrome with bilateral cryptorchidism. Arch Androl 1994, 32:135.
459. Petry K.G., Reichardt J.K. The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry. Trends Genet 1998, 14:98.
460. Prestoz L.L., Couto A.S., Shin Y.S., et al. Altered follicle stimulating hormone isoforms in female galactosaemia patients. Eur J Pediatr 1997, 156:116.
461. Angelopoulou N., Souftas V., Skadamis A., et al. Gonadal function in young women with Down syndrome. Int J Gynaecol Obstet 1999, 67:15.
462. Hsiang Y.H., Berkovitz G.D., Bland G.L., et al. Gonadal function in patients with Down syndrome. Am J Med Genet 1987, 27:449.
463. Roizen N.J., Patterson D. Down's syndrome. Lancet 2003, 361:1281.
464. Toledo S.P., Brunner H.G., Kraaij R., et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 1996, 81:3850.
465. Stavrou S.S., Zhu Y.S., Cai L.Q., et al. A novel mutation of the human luteinizing hormone receptor in 46,XY and 46,XX sisters. J Clin Endocrinol Metab 1998, 83:2091.
466. Muller T., Gromoll J., Simoni M. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J Clin Endocrinol Metab 2003, 88:2242.
467. Aittomaki K., Herva R., Stenman U.H., et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 1996, 81:3722.
468. Allen L.A., Achermann J.C., Pakarinen P., et al. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics. Hum Reprod 2003, 18:251.
469. Doherty E., Pakarinen P., Tiitinen A., et al. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab 2002, 87:1151.
470. Tapanainen J.S., Aittomaki K., Min J., et al. Men hormozygous for an inactivating mutation of the follicle-stimulating (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 1997, 15:205.
471. Bose H.S., Sugawara T., Strauss J.F., et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia: International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 1996, 335.
472. Bose H.S., Pescovitz O.H., Miller W.L. Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 1997, 82:1511.
473. Baker B.Y., Lin L., Kim C.J., et al. Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J Clin Endocrinol Metab 2006, 91:4781.
474. van den Akker E.L.T., Koper J.W., Boehmer A.L.M., et al. Differential inhibition of 17?-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450cl7 deficiency. J Clin Endocrinol Metab 2002, 87:5714.
475. Auchus R.J., Miller W.L. Molecular modelin of human P450cl7. (17?-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol Endocrinol 1999, 13:1169.
476. Morishima A., Grumbach M.M., Simpson E.R., et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995, 80:3689.
477. Herrmann B.L., Saller B., Janssen O.E., et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 2002, 87:5476.
478. Lee Y.S., Kirk J.M., Stanhope R.G., et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxf) 2007, 67:20.
479. Sinnecker G.H., Hiort O., Dibbelt L., et al. Phenotypic classification of male pseudohermaphroditism due to steroid 5-alpha-reductase 2 deficiency. Am J Med Genet 1996, 63:223.
480. Rodien P., Mebarki F., Mowszowicz I., et al. Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocr Metab 1996, 81:2994.
481. Gottlieb B., Trifiro M., Lumbroso R., et al. The androgen receptor gene mutations database. Nucleic Acids Res 1997, 25:158.
482. Adachi M., Takayanagi R., Tomura A., et al. Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med 2000, 343:856.
483. Economy K.E., Barnewolt C., Laufer M.R. A comparison of MRI and laparoscopy in detecting pelvic structures in cases of vaginal agenesis. J Pediatr Adolesc Gynecol 2002, 15:101.
484. Hickey M., Balen A. Menstrual disorders in adolescence: investigation and management Hum Reprod Update 2003, 9:493.
485. Gell J.S. Mullerian anomalies. Semin Reprod Med 2003, 21:375.
486. Shalet S.M., Tsatsoulis A., Whitehead E., et al. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol 1988, 120:161.
487. Castillo L.A., Craft A.W., Kernahan J. Gonadal function after 12-Gy testicular irradiation in childhood acute lymphoblastic leukaemia. Med Paediatr Oncol 1990, 18:185.
488. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999, 33:2.
489. Schmiegelow M., Lassen S., Poulsen H.S., et al. Gonadal status in male survivors following childhood brain tumors. J Clin Endocrinol Metab 2001, 86:2446.
490. Mayer E.I., Dofper R.E., Klingebiel T., et al. Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatr Transplant 1999, 3:38.
491. Müller J. Disturbance of pubertal development after cancer treatment. Best Pract Res Clin Endocrinol Metab 2002, 16:91.
492. Ankarberg-Lindgren C., Elfving M., Albertsson-Wikland K., et al. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 2001, 86:3039.
493. Ismail-Pratt I.S., Bikoo M., Liao L.M., et al. Normalization of the vagina by dilator treatment alone in complete androgen insensitivity syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome. Hum Reprod 2007, 22:2020.
494. Swerdloff R.S., Wang C., Cunningham G., et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 2000, 85:4500.
495. Wichstrom L. Predictors of adolescent suicide attempts: a nationally representative longitudinal study of Norwegian adolescents. J Am Acad Child Adolesc Psychiatry 2000, 39:603.
496. Ge X., Conger R.D., Elder G.H. Coming of age too early: pubertal influences on girls' vulnerability to psychological distress. Child Dev 1996, 67:3386.
497. Baumann D.A., Landolt M.A., Wetterwald R., et al. Psychological evaluation of young women after medical treatment for central precocious puberty. Horm Res 2001, 56:45.
498. Dorn L.D., Hitt S.F., Rotenstein D. Biopsychological and cognitive differences in children with premature vs. on-time adrenarche. Arch Pediatr Adolesc Med 1999, 153:137.
499. Dahl R.E. Adolescent brain development: A period of vulnerabilities and opportunities. Keynote address. Ann NY Acad Sci 2004, 1021:1.
500. Lalos A. Breaking the bad news concerning fertility. Hum Reprod 1999, 14:581.
501. Pitteloud N., Boepple P.A., DeCruz S., et al. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab 2001, 86:2470.